LP
DRTSW icon

LMR Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

LMR Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Buy
409,647
+296,661
+263% +$285K ﹤0.01% 1102
2025
Q4 		$38.4K Hold
112,986
– – ﹤0.01% 1391
2025
Q3 		$39K Hold
112,986
– – ﹤0.01% 1321
2025
Q2 		$27.1K Hold
112,986
– – ﹤0.01% 1248
2025
Q1 		$26.8K Hold
112,986
– – ﹤0.01% 1225
2024
Q4 		$23.7K Buy
+112,986
New +$23.1K ﹤0.01% 1077
2024
Q3 		– Sell
-112,986
Closed -$23.3K – 1347
2024
Q2 		$25.8K Hold
112,986
– – ﹤0.01% 969
2024
Q1 		$28.3K Hold
112,986
– – ﹤0.01% 1019
2023
Q4 		$21.8K Hold
112,986
– – ﹤0.01% 831
2023
Q3 		$30K Hold
112,986
– – ﹤0.01% 756
2023
Q2 		$44.6K Hold
112,986
– – ﹤0.01% 673
2023
Q1 		$324K Hold
112,986
– – 0.01% 788
2022
Q4 		$359K Hold
112,986
– – 0.01% 925
2022
Q3 		$660K Buy
112,986
+45,500
+67% +$26.8K 0.01% 830
2022
Q2 		$608K Buy
67,486
+42,486
+170% +$23.7K 0.01% 868
2022
Q1 		$295K Buy
+25,000
New +$13.6K ﹤0.01% 1084

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LMR Partners's DRTSW Position: Q1 2026 in Review

LMR Partners increased its Alpha Tau Medical Warrant (DRTSW) stake by 263% in Q1 2026, buying an estimated $285K and bringing the position to 409,647 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

LMR Partners first reported a position in DRTSW in Q1 2022 and has held it in 16 quarters since. The position peaked at $660K in Q3 2022. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

  • LMR Partners held 409,647 shares of Alpha Tau Medical Warrant worth $410K as of Q1 2026.
  • LMR Partners bought 296,661 Alpha Tau Medical Warrant shares in Q1 2026, an estimated $285K.
  • Alpha Tau Medical Warrant made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1102 holding.
  • LMR Partners first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 16 quarters since.
  • LMR Partners's Alpha Tau Medical Warrant position peaked at $660K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.